Os níveis séricos de Cyfra 21-1 são factores preditivos da sobrevida dos doentes com carcinoma pulmonar de não pequenas células submetidos a gefitinib como terapêutica de terceira linha

Autor:	Christophe Doddoli, C. Tchouhadjian, Jean-Pierre Kleisbauer, Fabrice Barlesi, Astoul P, J.-P. Torre
Rok vydání:	2005
Předmět:	lcsh:RC705-779 Pulmonary and Respiratory Medicine business.industry Medicine lcsh:Diseases of the respiratory system business
Zdroj:	Revista Portuguesa de Pneumologia, Vol 11, Iss 4, Pp 413-415 (2005)
ISSN:	0873-2159
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d07d83a7b5db5588c5543243627b120 https://doi.org/10.1016/s0873-2159(15)30508-0 Zobrazit plný text záznamu